Tadalista Professional Dosage and Administration Guide

Other > tadalista professional


Results in ED Population in US Trials—The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hicontentic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices.

Mechanism Aspect Description Effect
PDE5 Inhibition Blocks phosphodiesterase type 5 enzyme Enhances blood flow to the penis
Smooth Muscle Relaxation Relaxes vascular smooth muscles Facilitates erection
Nitric Oxide Release Promotes nitric oxide production Initiates penile erection

In each of these 2 trials, tadalafil tablets 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables ( see Table 11). The treatment effect of tadalafil tablets did not diminish over time. Table 11: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Primary US Results in General ED Population in Trials Outside the US— The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hicontentic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration.

Other uses for this medicine

Results in ED Population in US Trials—The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hicontentic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>90%) patients reported ED of at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices.

17.5 Potential for Drug Interactions When Taking tadalafil tablets for Once Daily Use

In each of these 2 trials, tadalafil tablets 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables ( see Table 11). The treatment effect of tadalafil tablets did not diminish over time. Table 11: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Primary US Results in General ED Population in Trials Outside the US— The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The population was 76% White, 1% Black, 3% Hicontentic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration.

5.11 Combination With Other PDE5 Inhibitors or Erectile Dysfunction Therapies

In these 5 trials, tadalafil tablets 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables ( see Tables 12, 13 and 14). Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the US Table 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 ("Were you able to insert your penis into the partner's vagina?") in the General ED Population in Five Pivotal Trials Outside the US Table 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 ("Did your erection last long enough for you to have successful intercourse?") in the General ED Population in Five Pivotal Trials Outside the US In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil tablets, compared to patients on placebo. Therefore, in all 7 primary efficacy and safety studies, tadalafil tablets showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries. Efficacy Results in ED Patients with Diabetes Mellitus— Tadalafil tablets were shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil tablets in ED patients with type 1 or type 2 diabetes (N=216). In these 5 trials, tadalafil tablets 5, 10, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables ( see Tables 12, 13 and 14). Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the US Table 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 ("Were you able to insert your penis into the partner's vagina?") in the General ED Population in Five Pivotal Trials Outside the US Table 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 ("Did your erection last long enough for you to have successful intercourse?") in the General ED Population in Five Pivotal Trials Outside the US In addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil tablets, compared to patients on placebo. Therefore, in all 7 primary efficacy and safety studies, tadalafil tablets showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries. Efficacy Results in ED Patients with Diabetes Mellitus— Tadalafil tablets were shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil tablets in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary cenforce 100mg tablet ( seeTable 15).

  • Tadalista Professional can interact with medications for blood pressure and prostate issues.
  • Do not combine with recreational drugs, especially nitrates or poppers.
  • Pregnant women should avoid handling or taking this medication.
  • Men with pre-existing eye conditions should discuss risks with a doctor.
  • Use caution if you have kidney or liver impairments.
  • Always follow prescribed dosing schedules to prevent complications.

Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with Diabetes Efficacy Results in ED Patients following Radical Prostatectomy— Tadalafil tablets was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy.

  • Patients should inform their doctor about current medications before starting Tadalista.
  • Tadalista Professional can be effective for men over 50 with age-related ED.
  • It is not recommended for use by women or children.
  • Proper hydration and a balanced diet help optimize medication effectiveness.
  • Overdose symptoms may include prolonged erections (priapism) and severe dizziness.
  • Seek immediate medical attention if adverse reactions occur.

In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( seeTable 16).

Product Dosage Quantity + Bonus Price
Kamagra Oral Jelly100mg63 + 7 Sachets224.18€ 213.50€
Kamagra 100 mg100 mg84 + 6 Pills264.44€ 251.85€
Super Kamagra160 mg12 Pills101.10€ 96.29€
Kamagra Soft Tabs100mg84 + 4 Pills233.05€ 221.95€
Cialis Black80mg270 + 10 Pills502.88€ 478.93€
Cialis Black80mg30 + 2 Pills89.11€ 84.87€
Viagra Generic150mg60 + 4 Pills111.25€ 105.95€
Cialis Generic40mg270 + 10 Pills382.19€ 363.99€
Tadalista Super Active20mg20 + 4 Pills92.35€ 87.95€
Apcalis SX Oral Jelly20mg30 + 5 Sachets141.84€ 135.09€
Viagra Original100mg4 Pills40.94€ 38.99€
Kamagra100mg120 + 6 Pills330.74€ 314.99€
Kamagra 100 mg100 mg180 + 6 Pills436.79€ 415.99€
Viagra Soft Tabs100mg120 + 8 Pills232.21€ 221.15€
Cialis Generic40mg90 + 6 Pills171.35€ 163.19€
Kamagra Oral Jelly100 mg90 + 8 Sachets303.56€ 289.10€
Viagra Professional100mg20 Pills71.14€ 67.75€

Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical Prostatectomy Results in Studies to Determine the Optimal Use of Tadalafil tablets— Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED.

How Does Tadalafil 20 mg Work?

In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary cenforce 100mg tablet ( seeTable 15). Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with Diabetes Efficacy Results in ED Patients following Radical Prostatectomy— Tadalafil tablets was shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( seeTable 16). Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical Prostatectomy Results in Studies to Determine the Optimal Use of Tadalafil tablets— Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined.

Serious side effects

In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, tadalafil tablets 10, or 20 mg. Using a stopwatch, patients recorded the time following dosing at which a successful erection was obtained. A successful erection was defined as at least 1 erection in 4 attempts that led to successful intercourse. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-, and 20-mg groups, respectively, reported successful erections as defined above. Two studies were conducted to assess the efficacy of tadalafil tablets at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing.

Vardenafil Solutions

In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil tablets 20 mg. Patients were encouraged to make 4 total attempts at intercourse; 2 attempts were to occur at 24 hours after dosing and 2 completely separate attempts were to occur at 36 hours after dosing. The results demonstrated a difference between the placebo group and the tadalafil tablets group tadalista super active 20 at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the tadalafil tablets 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil tablets 20-mg group. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined. In this randomized, placebo-controlled, double-blinded trial, 223 patients were randomized to placebo, tadalafil tablets 10, or 20 mg.

  • Tadalista Professional offers a longer duration of effect compared to other ED meds.
  • It is available by prescription and should be used under medical supervision.
  • Common side effects include headache, flushing, nasal congestion, and dizziness.
  • Avoid consuming large amounts of alcohol while using Tadalista Professional.
  • Do not take more than one dose in 24 hours to avoid adverse effects.
  • Store in a cool, dry place away from direct sunlight and moisture.

Using a stopwatch, patients recorded the time following dosing at which a successful erection was obtained.

  • Tadalista Professional helps improve confidence by providing reliable erections.
  • It does not cause spontaneous erections; sexual stimulation is still required.
  • The medication is often preferred for its quick onset and long duration.
  • It is not suitable for individuals with severe heart or liver problems.
  • Possible drug interactions include nitrates and certain antihypertensives.
  • Always follow your healthcare provider’s instructions for use and dosage.

A successful erection was defined as at least 1 erection in 4 attempts that led to successful intercourse. At or prior to 30 minutes, 35% (26/74), 38% (28/74), and 52% (39/75) of patients in the placebo, 10-, and 20-mg groups, respectively, reported successful erections as defined above.

Contraindication Explanation Alternative Approach
Use of nitrates Can cause severe hypotension Consult healthcare provider
Severe cardiovascular disease Increased risk during sexual activity Medical evaluation recommended
Hypersensitivity to Tadalafil Possible allergic reactions Avoid medication
Severe liver or kidney impairment Affects drug metabolism Dose adjustment or alternative drugs

Two studies were conducted to assess the efficacy of tadalafil tablets at a given timepoint after dosing, specifically at 24 hours and at 36 hours after dosing. In the first of these studies, 348 patients with ED were randomized to placebo or tadalafil tablets 20 mg. Patients were encouraged to make 4 total attempts at intercourse; 2 attempts were to occur at 24 hours after dosing and 2 completely separate attempts were to occur at 36 hours after dosing. The results demonstrated a difference between the placebo group and the tadalafil tablets group tadalista super active 20 at each of the pre-specified timepoints. At the 24-hour timepoint, (more specifically, 22 to 26 hours), 53/144 (37%) patients reported at least 1 successful intercourse in the placebo group versus 84/138 (61%) in the tadalafil tablets 20-mg group. At the 36-hour timepoint (more specifically, 33 to 39 hours), 49/133 (37%) of patients reported at least 1 successful intercourse in the placebo group versus 88/137 (64%) in the tadalafil tablets 20-mg group. In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil tablets 10, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing). Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the tadalafil tablets groups at each of the pre-specified timepoints. At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, tadalafil tablets 10-, and 20-mg groups, respectively. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, tadalafil tablets 10-, and 20-mg groups, respectively.

Dose (mg) Typical Use Maximum Daily Dose Onset Time Duration of Action
20 Initial treatment for ED 20 About 30-60 min Up to 36 hours
10 Mild to moderate ED 10 About 30 min Up to 36 hours
5 For sensitive patients or low-dose needs 5 About 30 min Up to 36 hours

The efficacy and safety of tadalafil tablets for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials buy super p force jelly of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. Tadalafil tablets, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).

What should I do if I forget a dose?

In the second of these studies, a total of 483 patients were evenly randomized to 1 of 6 groups: 3 different dosing groups (placebo, tadalafil tablets 10, or 20 mg) that were instructed to attempt intercourse at 2 different times (24 and 36 hours post-dosing). Patients were encouraged to make 4 separate attempts at their assigned dose and assigned timepoint. In this study, the results demonstrated a statistically significant difference between the placebo group and the tadalafil tablets groups at each of the pre-specified timepoints. At the 24-hour timepoint, the mean, per patient percentage of attempts resulting in successful intercourse were 42, 56, and 67% for the placebo, tadalafil tablets 10-, and 20-mg groups, respectively. At the 36-hour timepoint, the mean, per-patient percentage of attempts resulting in successful intercourse were 33, 56, and 62% for placebo, tadalafil tablets 10-, and 20-mg groups, respectively.

17.1 Nitrates

The efficacy and safety of tadalafil tablets for once daily use in the treatment of erectile dysfunction has been evaluated in 2 clinical trials buy super p force jelly of 12-weeks duration and 1 clinical trial of 24-weeks duration, involving a total of 853 patients. Tadalafil tablets, when taken once daily, was shown to be effective in improving erectile function in men with erectile dysfunction (ED). Tadalafil tablets were studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively. One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus.

When is the best time to take Tadalafil 20 mg?

Tadalafil tablets were taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. Timing of sexual activity was not restricted relative to when patients took tadalafil tablets. Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years). The population was 86% White, 6% Black, 6% Hicontentic, and 2% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Tadalafil tablets were studied in the general ED population in 2 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12- and 24-weeks duration, respectively. One of these studies was conducted in the United States and one was conducted in centers outside the US. An additional efficacy and safety study was performed in ED patients with diabetes mellitus.

What is Tadalista Professional For

Most (>96%) patients reported ED of at least 1-year duration. The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56 years (range 21 to 78 years). The population was 86% White, 3% Black, 0.4% Hicontentic, and 10% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Ninety-three percent of patients reported ED of at least 1-year duration. In each of these trials, conducted without regard to the timing of dose and sexual intercourse, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( seeTable 17).

Drug Interactions of Tadalista Professional 20 mg?

When taken as directed, tadalafil tablets were effective at improving erectile function. In the 6 month double-blind study, the treatment effect of tadalafil tablets did not diminish over time. Table 17: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Tadalafil tablets for Once Daily Use Studies aTwenty-four-week study conducted in the US. Tadalafil tablets were taken once daily at doses ranging from 2.5 to 10 mg. Food and alcohol intake were not restricted. Timing of sexual activity was not restricted relative to when patients took tadalafil tablets. Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years). The population was 86% White, 6% Black, 6% Hicontentic, and 2% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (>96%) patients reported ED of at least 1-year duration. The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56 years (range 21 to 78 years). The population was 86% White, 3% Black, 0.4% Hicontentic, and 10% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Ninety-three percent of patients reported ED of at least 1-year duration. In each of these trials, conducted without regard to the timing of dose and sexual intercourse, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary ( seeTable 17). When taken as directed, tadalafil tablets were effective at improving erectile function. In the 6 month double-blind study, the treatment effect of tadalafil tablets did not diminish over time. Table 17: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Tadalafil tablets for Once Daily Use Studies aTwenty-four-week study conducted in the US.